Pricing Log in Create free account

Pelthos Therapeutics Inc. (PTHS) vs Telomir Pharmaceuticals, Inc. (TELO)

Pelthos Therapeutics Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Pelthos Therapeutics Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($77.6M and $77.3M). Telomir Pharmaceuticals, Inc. has the higher net margin (0.00% vs −199.5%) and the higher return on invested capital (0.00% vs −82.3%). Across the 12 metrics below, Telomir Pharmaceuticals, Inc. leads on 8 and Pelthos Therapeutics Inc. on 4.

Valuation

Metric PTHS TELO Biotechnology median
P/E n/m n/m 8.50
P/S 1.65 n/m 9.71
P/B n/m 12.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.75 n/m 9.21
Earnings yield (142.54%) (85.85%) (33.15%)
Free cash flow yield (59.72%) (7.62%) (25.50%)

Profitability

Metric PTHS TELO Biotechnology median
Gross margin 78.59% — 65.16%
Operating margin (133.42%) 0.00% 0.00%
Net margin (199.50%) 0.00% 0.00%
Free cash flow margin (98.37%) 0.00% 0.00%
Return on equity 2,161.07% (1,885.50%) (56.36%)
Return on assets (125.04%) (1,678.31%) (48.04%)
Return on invested capital (82.34%) 0.00% 0.00%

Growth

Metric PTHS TELO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (61.12%) 41.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric PTHS TELO Biotechnology median
Debt to equity (46.58) 0.03 0.00
Current ratio 1.98 16.14 4.72
Net debt to EBITDA (0.45) 0.69 0.96

Dividend

Metric PTHS TELO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PTHS TELO Biotechnology median
Market cap 77.57m 77.30m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack